A new international awards program intended to recognise everyday people who serve as carers has been launched by Shire Pharmaceuticals, the global specialty biopharmaceutical company. The Shire BRAVE Awards is the first and only awards initiative of its kind and is designed to recognise the courage and dedication of non-professional carers, honouring everyday heroes who provide regular, consistent care of another person.
“The BRAVE Awards honour some of the bravest people in the world – those who give their time, support and compassion to care for a relative, neighbour or friend,” said Angus Russell, Shire Chief Executive Officer. “At Shire, we believe that carers are often the unsung heroes and we hope the BRAVE Awards will draw attention to the important and sometimes undervalued role that mums, dads, brothers, sisters, aunts, uncles, friends, neighbours or frankly anyone in the community can play in the life of others around the world.”
Nominations for the Shire BRAVE Awards are being accepted through the official website at www.ShireBRAVEawards.com between June 15 and August 31, 2011 and winners will be announced in November 2011. The submission process is straightforward: consider a carer who you believe deserves recognition; visit the website to learn more; and complete the online nomination form, which requires nominators to share the story of a carer believed to be worthy of receiving a Shire BRAVE Award.
A carer is defined by the Shire BRAVE Awards as an individual who is providing regular, consistent care for another person. The carer can be a relative, neighbour, or friend who gives their time, support, and compassion regularly, helping another person who is not able to care for themselves. The caregiver cannot be a professional healthcare provider and cannot be compensated in any formal way through their employment as a caregiver. Doctors, nurses, hospital staff and other healthcare workers are not eligible. Nominees must be age 18 or older as of August 31, 2011. In 2011, its first year, the Shire BRAVE Awards are open to eligible nominees in France, Germany, Italy, Spain, the United Kingdom, and the United States.
A Selection Committee consisting of Shire employees and non-Shire representatives will choose the finalists. Shire’s 4,700 employees across the world will then be invited to select up to ten (10) winners from the pool of eligible finalists through an online voting system, and each winner will receive $10,000 USD or local currency equivalent.
The Shire BRAVE Awards are presented in the spirit of Shire’s BRAVE culture, which fosters an environment that encourages its employees and partners to act with integrity; create innovative solutions that make a difference; act on the needs of others; strive to be better everyday; and to exemplify trust and openness through teamwork.
For further information please contact:
Matthew Cabrey ([email protected]) +1 484 595 8248
Jessica Mann ([email protected]) +44 1256 894 280
Robert Stanislaro ([email protected]) +1 212 850 5657
Ben Atwell ([email protected]) +44 2072 697 242
Notes to editors
About the Shire BRAVE Awards
Shire’s strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire (LSE: SHP, NASDAQ: SHPGY) focuses its business on attention deficit hyperactivity disorder (ADHD), human genetic therapies (HGT) and gastrointestinal (GI) diseases as well as opportunities in other therapeutic areas to the extent they arise through acquisitions. Shire’s in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights. Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.
For further information on Shire, please visit the Company’s website: www.shire.com.